HL Financial Services LLC Has $2.75 Million Stake in Baxter International Inc (BAX)

HL Financial Services LLC lifted its position in shares of Baxter International Inc (NYSE:BAX) by 4.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,188 shares of the medical instruments supplier’s stock after purchasing an additional 1,488 shares during the quarter. HL Financial Services LLC’s holdings in Baxter International were worth $2,746,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Migdal Insurance & Financial Holdings Ltd. grew its stake in Baxter International by 3,088.9% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,435 shares of the medical instruments supplier’s stock valued at $106,000 after acquiring an additional 1,390 shares during the period. Ostrum Asset Management acquired a new stake in Baxter International in the 1st quarter valued at $121,000. Whittier Trust Co. of Nevada Inc. grew its stake in Baxter International by 84.4% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,748 shares of the medical instruments supplier’s stock valued at $126,000 after acquiring an additional 800 shares during the period. Vigilant Capital Management LLC acquired a new stake in Baxter International in the 2nd quarter valued at $131,000. Finally, IHT Wealth Management LLC grew its stake in Baxter International by 71.9% in the 1st quarter. IHT Wealth Management LLC now owns 2,462 shares of the medical instruments supplier’s stock valued at $156,000 after acquiring an additional 1,030 shares during the period. 82.92% of the stock is currently owned by institutional investors and hedge funds.

Shares of BAX stock opened at $70.71 on Wednesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.00 and a current ratio of 2.62. The firm has a market capitalization of $38.20 billion, a price-to-earnings ratio of 28.51, a PEG ratio of 1.79 and a beta of 0.77. Baxter International Inc has a fifty-two week low of $60.13 and a fifty-two week high of $76.51.



Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, July 26th. The medical instruments supplier reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.06. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.83 billion. Baxter International had a return on equity of 16.63% and a net margin of 8.29%. The firm’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.63 EPS. sell-side analysts expect that Baxter International Inc will post 2.98 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 1st. Shareholders of record on Friday, August 31st will be issued a $0.19 dividend. The ex-dividend date of this dividend is Thursday, August 30th. This represents a $0.76 dividend on an annualized basis and a yield of 1.07%. Baxter International’s payout ratio is currently 30.65%.

A number of equities research analysts recently issued reports on the stock. Zacks Investment Research cut shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Thursday, May 31st. JPMorgan Chase & Co. lifted their price target on shares of Baxter International from $80.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, July 27th. Citigroup lifted their price target on shares of Baxter International from $74.00 to $76.00 and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Bank of America lifted their price target on shares of Baxter International from $73.00 to $83.00 and gave the company a “buy” rating in a research note on Tuesday, May 22nd. Finally, Piper Jaffray Companies assumed coverage on shares of Baxter International in a research note on Thursday, May 17th. They issued an “overweight” rating and a $77.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $76.00.

In other Baxter International news, SVP Scott Pleau sold 27,197 shares of the firm’s stock in a transaction on Monday, June 25th. The stock was sold at an average price of $73.57, for a total value of $2,000,883.29. Following the transaction, the senior vice president now owns 47,363 shares in the company, valued at approximately $3,484,495.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Carole J. Shapazian sold 6,594 shares of the firm’s stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $71.79, for a total value of $473,383.26. Following the completion of the transaction, the director now owns 16,442 shares in the company, valued at approximately $1,180,371.18. The disclosure for this sale can be found here. Insiders sold a total of 74,877 shares of company stock worth $5,468,755 in the last 90 days. 0.07% of the stock is currently owned by insiders.

Baxter International Profile

Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: Growth Stocks, What They Are, What They Are Not

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply